-
FDA advisors recommend approval of obesity drug Qnexa
-
Scar on MRI portends poor outcome in viral myocarditis
-
Interventional live case demos are safe, small study shows
-
Montreal cardiologists accused of taking bribes from patients
-
AV nodal ablation ups survival in AF patients with CRT
-
Is new gene analysis the final chapter in the homocysteine saga?
-
Six of seven guideline-recommended HF therapies lower mortality at two years
-
Young women with MI most likely to have no chest pain
-
Detailed family history improves cardiovascular disease risk assessment
-
Crossing tricuspid-valve bioprosthesis with pacer/ICD lead generally safe
-
Resolute zotarolimus stent approved in US
-
Pregnancy complications up CVD risk by 30%
-
EMA: New aliskiren restrictions and decisions on aprotinin, orlistat
-
Ten-month Medicare "doc fix" passes Congress, heads for White House
-
Mutations in giant gene a major cause of familial DCM
-
CardioGen-82 returns to market
-
Exercise, regardless of amount of sedentary time, improves risk factors in kids
-
Stem-cell therapy still needs a lot more study
-
New ACCP thrombosis guidelines offer weak support for aspirin in primary prevention
-
Short-term exposure to air pollutants ups MI risk: Meta-analysis
-
Vitamin D in CKD: No benefit for CV function, structure
-
Cardiac stem-cells increase viable myocardium post-MI: CADUCEUS
-
No cancer protection with vitamin B or omega-3 fatty-acid supplements
-
Fidelis failures climb: "Strongly consider" replacement at ICD change-out
-
New mitral-repair therapies face obstacles
-
More doctors advising patients to exercise
-
More hope for factor Xa reversal
-
The doctor will see you now (from the other side of the world)
-
US judge upholds FDA approval of generic enoxaparin
-
Biomarker may distinguish ICH from ischemic stroke
-
Over 1300 deaths in Mediator scandal in France
-
Referring MDs fall short on ICD-indication guidelines
-
Apixaban superior for AF patients with previous stroke, TIA
-
Ten foods provide half of sodium eaten in US
-
Like father, like son: Y-chromosome variant may explain CAD
-
Wide variation in PCI for "unclear indications"
-
PCI appropriateness criteria draw criticism
-
More bleeding, thromboembolic events with dabigatran in AF ablation
-
For stroke risk, look for novel lipid/lipoprotein biomarkers
-
Braile Biomédica launches transapical valve
-
Wake-up stroke patients may still benefit from thrombolysis
-
Generalists need education on HF treatment
-
SWITCH III: Bivalirudin is as safe as heparin after fondaparinux in PCI patients
-
TRA 2°P: Vorapaxar meets end point but ups bleeding
-
CTO, even in non-infarct-related artery, bodes ill in NSTEMI patients
-
ICDs charged with sex discrimination: Women get fewer shocks
-
Fitness and fatness independently linked with CVD risk factors
-
MI-shock proposal is cold comfort: Hypothermia might boost survival
-
Dr Paolo Raggi joins University of Alberta
-
Lower mortality in NFL players—if weight is kept in check
-
KEEP: Focus on CKD patients with highest SBP
-
"Irrational" choices stall adoption of new antiplatelets
-
Sitagliptin/metformin once-daily combo approved for diabetes
-
No recurrent stroke prevention seen with clopidogrel plus aspirin
-
Heart failure linked to loss of brain gray matter
-
Photos on school lunch trays boost veggie intake
-
Aspirin as effective as warfarin in heart failure: WARCEF
-
"Tetherless" power-transmission technology could radically change LVAD therapy
-
CMS draft of proposed coverage for TAVI
-
Severe anemia potent predictor of death poststroke
-
Cardiac telemetry identifies AF in cryptogenic stroke
-
The flap over flavonoids
-
Severe, rapid memory loss could herald stroke
-
Dr Mandeep Mehra leaves Baltimore for post at the Brigham
-
"Cardiovascular health," new focus of the AHA, linked with reduced mortality
-
US "roadmap" for TAVI rollout published
-
Restenosis similar with carotid stenting or surgery: CREST
-
Stroke risk linked to infections in children
-
Combination type 2 diabetes pill gets FDA nod
-
Shifty and dangerous: Worsening diastolic dysfunction ups mortality
-
"Valve-on-a-stick" transaortic TAVI offers alternative to transfemoral route
-
New data will shed light on cancer risk from imaging
-
Dr Robert Harrington leaves DCRI for Stanford University
-
PARTNER CAP data show transapical outcomes improve with practice
-
SYNTAX, FAME trials influence update to PCI/CABG appropriate-use criteria
-
Once-weekly exenatide okayed by FDA for type 2 diabetes
-
Women do better after TAVI, hints small study
-
Statins reduce cardiovascular events and all-cause mortality in women: Meta-analysis
-
ASCERT: Better survival for CABG vs PCI in some high-risk patients
-
Interarm BP differences increase CVD risk
-
3B or not 3B? Should patients get an LVAD before reaching end-stage HF?
-
Surgeons insist TAVI reimbursement rollout won't be repeat of carotid-stenting debacle
-
Don't routinely replace spent ICDs: Proposal
-
Data mixed on role of parents and caregivers in combating childhood obesity
-
More data needed on carotid atherosclerosis, CMS advisers agree
-
Contaminated cardiac drugs kill more than 100 in Pakistan
-
Riata Summit insights: Vigilance key to following functional but "recalled" ICD leads
-
Proximal balloon superior to distal protection in carotid artery stenting
-
Dr Gary Roubin to resign as CV chair at Lenox Hill
-
Heart attack deaths plummet in three EU nations
-
Heart disease risk begins with middle-age risk factors
-
Cardiologists flagging woeful patient care say they paid with their jobs
-
Vytorin US label updated with SHARP results
-
Pay for SGR repeal with war savings, say medical groups
-
Black tea lowers blood pressure in small trial
-
PLATO: PPI analysis "raises flag" but should not change practice
-
Carotid images don't boost quit rates or cut CV risk factors in smokers
-
Cardiologists accused of defrauding Medicare by performing unnecessary cardiac procedures
-
Gifts, pep talks have some success post-PCI and in hypertension
-
To prescribe or not to prescribe: That is the statin question, experts debate
-
"Recalled" Riata ICD leads: Brainstorming conference aims for guidance
-
EMA investigating CV problems with fingolimod
-
Dapagliflozin declined by FDA
-
Lower mortality rates at two years with transradial PCI, Italian registry shows
-
Pillow talk: First AHA advice on sex and CVD
-
Treat risk and not LDL-cholesterol targets, new perspective argues
-
"High-normal" blood pressure linked to AF
-
New AF ablation programs need time, money, and data
-
FFR shows benefit in FAME II; enrollment halted
-
Mortality climbs with rising PA pressure in heart failure: Community-based study
-
Contemporary look at VTE after joint surgery
-
BRIDGE study published: Cangrelor suited for important antiplatelet niche
-
NHANES: One in three adults, one in six children obese
-
Dronedarone gets another chance to prove itself in ranolazine combo trial
-
CCTA is less useful in patients with high calcium score
-
Thoracic endoprosthesis gets traumatic transection approval
-
New AF ablation consensus doc previewed at Boston AF symposium
-
Resveratrol scientists react to Das fraud scandal: "Research will continue"
-
Yoga therapy for AF yields insight into brain-heart axis
-
FDA: CardioGen-82 problems site-specific
-
Red-wine researcher charged with photo-editing fraud
-
US bleeding ADRs higher with dabigatran than warfarin
-
Silent atrial fibrillation increases stroke risk
-
Very low risk of cardiac arrest and sudden death in long-distance running events
-
Statins cost four times more in US than UK
-
Inactivity is a universal risk factor for heart attack
-
Pulmonary hypertension in kids differs from adult PAH
-
Venous thrombosis, pulmonary embolism raise mortality risk
-
GWTG improves AMI care in Asian Americans
-
Serum potassium targets in acute MI need rethink, analysis suggests
-
New DES best older stents for deaths, restenosis in latest SCAAR data
-
Aspirin in primary prevention: New meta-analysis finds bleeding outweighs benefits for most
-
New guidelines suggest blood glucose testing for all inpatients
-
Aortic stenosis grading system misses rare, high-risk group
-
Dabigatran: New data on MI and ischemic events
-
Statin use associated with significantly increased risk of diabetes: WHI analysis
-
Bereavement triggers MI, new study finds
-
UK's NICE wants more data on rivaroxaban in AF
-
Informed consent questioned in Florida patient's death after stem-cell treatment
-
MitraClip: Encouraging results in nonsurgical patients
-
Complications, rehospitalizations not uncommon post-AF ablation
-
Novel LDL-gene-targeted agent promising
-
Excess calories, not proportion of dietary protein, key in causing obesity
-
RESPECT PFO/stroke trial completes enrollment
-
Public Citizen requests recall of the Wingspan stent
-
BRCA1 cancer gene affects cardiac function
-
Rivaroxaban filed for ACS in US and EU
-
Type 2 diabetes adds risk to tissue valves
-
US leads in shorter hospital stays, early readmission after STEMI
-
Bariatric surgery reduces CV events, but mechanisms remain a mystery
-
Enoxaparin prophylaxis doesn't cut mortality in acute-care setting
-
Mayo report: It takes docs about 30 TAVIs to achieve proficiency
-
Analysis slams use of clopidogrel loss-of-function gene test; proponents fire back
-
Troponins at admission and three hours allow MI diagnosis or rule-out